With 10 years of experience in targeted therapies and molecular diagnostics, KPS operates a state-of-the-art molecular pathology diagnostic lab. They are certified by the European Association of Pathologists and serve as a partner reference lab for leading pharmacology companies. KPS offers proprietary bioinformatic services for the interpretation of molecular diagnostics and can currently test 58 genes, providing information on over 200 targeted anticancer drugs. Their mission is to translate medical discoveries into clinical practice and reduce ineffective treatments, ensuring that lack of information is never an obstacle for cancer patients.